Please enable Javascript and disable ad blockers

Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Press Release: KPN nominates Frank Heemskerk to Supervisory Board and proposes to reappoint Jolande SapPhoto, wide shot, wide-angle lens, Mobile phone network, sunset photo at golden hour, photo by Thomas Heaton: https://img.theapi.app/temp/828b91fb-678a-4621-906b-21e972059e7d.png

Press Release: KPN nominates Frank Heemskerk to Supervisory Board and proposes to reappoint Jolande Sap

Press Release: KPN nominates Frank Heemskerk to Supervisory Board and proposes to reappoint Jolande Sap

0

EQS-News: Nordex Group generates order intake of 6.3 GW in the fiscal year 2022Photo, wide shot, wide-angle lens, Heavy machinery, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://img.midjourneyapi.xyz/temp/c15253b0-7330-4605-a666-66954eaf6715.png

EQS-News: Nordex Group generates order intake of 6.3 GW in the fiscal year 2022

EQS-News: Nordex Group generates order intake of 6.3 GW in the fiscal year 2022

0

EQS-News: STEMMER IMAGING confirms growth prospects with record order in the Artificial Vision segmentPhoto, wide shot, wide-angle lens, Consumer electronics manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/0defe5ca-333a-451e-9549-4f262e278fc7.png

EQS-News: STEMMER IMAGING confirms growth prospects with record order in the Artificial Vision segment

EQS-News: STEMMER IMAGING confirms growth prospects with record order in the Artificial Vision segment

0

Lindt & Sprüngli reports strong sales growthPhoto, wide shot, wide-angle lens, Supermarket, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.theapi.app/temp/12c4d93c-5c0e-4e39-8e32-e47404ce9d79.png

Lindt & Sprüngli reports strong sales growth

Lindt & Sprüngli reports strong sales growth

0

Kinarus Therapeutics Reports Preclinical Data in Lung Fibrosis and Discloses Clinical Development PlanPhoto, wide shot, wide-angle lens, Logistics company, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/a16a79c7-f73c-405d-ba63-e8d69b66ce4e.png

Kinarus Therapeutics Reports Preclinical Data in Lung Fibrosis and Discloses Clinical Development Plan

Kinarus Therapeutics Reports Preclinical Data in Lung Fibrosis and Discloses Clinical Development Plan

0

Bellevue Asset Management launches debut private equity secondaries fundPhoto, wide shot, wide-angle lens, Hedge fund, neutral atmosphere, photo by Charlie Waite: https://img.theapi.app/temp/95282efd-f725-49c0-be40-aa74627f7ccc.png

Bellevue Asset Management launches debut private equity secondaries fund

Bellevue Asset Management launches debut private equity secondaries fund

0

Relief Therapeutics Announces IRB Approval of Investigator-Initiated Trial Evaluating RLF-TD011 as an Adjunctive Treatment for Cutaneous T-Cell LymphomPhoto, wide shot, wide-angle lens, soft focus, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-d5U47McddROtnUwv1JIaZvc2.png?st=2023-05-04T16%3A11%3A57Z&se=2023-05-04T18%3A11%3A57Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T16%3A04%3A37Z&ske=2023-05-05T16%3A04%3A37Z&sks=b&skv=2021-08-06&sig=KvGLXJQj4L2uYw31IYBsPpHX4telRq/7natMW2uEF58%3D

Relief Therapeutics Announces IRB Approval of Investigator-Initiated Trial Evaluating RLF-TD011 as an Adjunctive Treatment for Cutaneous T-Cell Lymphom

Relief Therapeutics Announces IRB Approval of Investigator-Initiated Trial Evaluating RLF-TD011 as an Adjunctive Treatment for Cutaneous T-Cell Lymphom

0

A sharp rise in the cost basis, delayed reaction to a decline in demand and the effect of one-time impacts in the second half of 2022 led to a significant reduction in EBIT and Group profit.Photo, wide shot, wide-angle lens, Toy manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/2788fcd3-d339-4592-8f5c-a3b9125dc61f.png

A sharp rise in the cost basis, delayed reaction to a decline in demand and the effect of one-time impacts in the second half of 2022 led to a significant reduction in EBIT and Group profit.

A sharp rise in the cost basis, delayed reaction to a decline in demand and the effect of one-time impacts in the second half of 2022 led to a significant reduction in EBIT and Group profit.

0

Christoph Tonini to become Delegate of the Board and CEO of SMG Swiss Marketplace Group and step down from his mandates at TX GroupPhoto, wide shot, wide-angle lens, soft focus, Movie theater, sunset photo at golden hour, photo by Marc Adamus: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-gXhfb5xMEy8zG0qLmxYAOaHt.png?st=2023-05-14T13%3A29%3A06Z&se=2023-05-14T15%3A29%3A06Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-14T01%3A25%3A03Z&ske=2023-05-15T01%3A25%3A03Z&sks=b&skv=2021-08-06&sig=cyWAC06qXhBJ4kv4K4eQVNNwtdGGK962uEjAh4%2B61ZY%3D

Christoph Tonini to become Delegate of the Board and CEO of SMG Swiss Marketplace Group and step down from his mandates at TX Group

Christoph Tonini to become Delegate of the Board and CEO of SMG Swiss Marketplace Group and step down from his mandates at TX Group

0

EQS-News: AURELIUS Equity Opportunities to seek segment changePhoto, wide shot, wide-angle lens, Private equity firm, sunset photo at golden hour, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/11edc0a6-edfc-46d1-baee-abd4f510abd1.png

EQS-News: AURELIUS Equity Opportunities to seek segment change

EQS-News: AURELIUS Equity Opportunities to seek segment change

0

EQS-Adhoc: Application for termination of stock exchange inclusion in Munich Photo, wide shot, wide-angle lens, Private equity firm, sunset photo at golden hour, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/11edc0a6-edfc-46d1-baee-abd4f510abd1.png

EQS-Adhoc: Application for termination of stock exchange inclusion in Munich

EQS-Adhoc: Application for termination of stock exchange inclusion in Munich

0

EQS-News: Westwing Group SE Trading Update: FY 2022 financial guidance confirmed; positive Adjusted EBITDA and Free Cash Flow in the fourth quarter of 2022

EQS-News: Westwing Group SE Trading Update: FY 2022 financial guidance confirmed; positive Adjusted EBITDA and Free Cash Flow in the fourth quarter of 2022

EQS-News: Westwing Group SE Trading Update: FY 2022 financial guidance confirmed; positive Adjusted EBITDA and Free Cash Flow in the fourth quarter of 2022

0

Affluent Medical : Affluent Medical strengthens its management team to support industrial and commercial deploymentPhoto, wide shot, wide-angle lens, Logistics company, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/a16a79c7-f73c-405d-ba63-e8d69b66ce4e.png

Affluent Medical : Affluent Medical strengthens its management team to support industrial and commercial deployment

Affluent Medical : Affluent Medical strengthens its management team to support industrial and commercial deployment

0

ROCTOOL: STANDEX ENGRAVING AND ROCTOOL SIGN GLOBAL AGREEMENTPhoto, wide shot, wide-angle lens, Heavy machinery, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://img.midjourneyapi.xyz/temp/c15253b0-7330-4605-a666-66954eaf6715.png

ROCTOOL: STANDEX ENGRAVING AND ROCTOOL SIGN GLOBAL AGREEMENT

ROCTOOL: STANDEX ENGRAVING AND ROCTOOL SIGN GLOBAL AGREEMENT

0

Key Figures

15.01.2023Photo, wide shot, wide-angle lens, Hedge fund, neutral atmosphere, photo by Charlie Waite: https://img.theapi.app/temp/95282efd-f725-49c0-be40-aa74627f7ccc.png

Key Figures 15.01.2023

Key Figures 15.01.2023

0

Invibes Advertising NV: Half-yearly report on the liquidity contract

Invibes Advertising NV: Half-yearly report on the liquidity contract

Invibes Advertising NV: Half-yearly report on the liquidity contract

0

EQS-News: va-Q-tec AG: Acceptance period for EQT Private Equity’s voluntary public takeover offer for va-Q-tec beginsPhoto, wide shot, wide-angle lens, Home appliance manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/5d70b6df-fa9b-4237-9702-39c36cb1d4f8.png

EQS-News: va-Q-tec AG: Acceptance period for EQT Private Equity’s voluntary public takeover offer for va-Q-tec begins

EQS-News: va-Q-tec AG: Acceptance period for EQT Private Equity’s voluntary public takeover offer for va-Q-tec begins

0

Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc

Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc

Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc

0

Form 8.3 - The Vanguard Group, Inc.: Micro Focus International plc

Form 8.3 - The Vanguard Group, Inc.: Micro Focus International plc

Form 8.3 - The Vanguard Group, Inc.: Micro Focus International plc

0

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plcPhoto, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

0

Form 8.3 - The Vanguard Group, Inc.: Devro plcPhoto, wide shot, wide-angle lens, Supermarket, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.theapi.app/temp/12c4d93c-5c0e-4e39-8e32-e47404ce9d79.png

Form 8.3 - The Vanguard Group, Inc.: Devro plc

Form 8.3 - The Vanguard Group, Inc.: Devro plc

0

Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc

Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc

Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc

0

Form 8.3 - The Vanguard Group, Inc.: Biffa plcPhoto, wide shot, wide-angle lens, Janitorial service, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/4d4e885c-79e9-4b8f-bd91-e9721cd7c2e9.png

Form 8.3 - The Vanguard Group, Inc.: Biffa plc

Form 8.3 - The Vanguard Group, Inc.: Biffa plc

0

Form 8.3 - The Vanguard Group, Inc.: AVEVA Group plcPhoto, wide shot, wide-angle lens, soft focus, IT consulting firm, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-uhXP0RHYYxDepjmHeSp1K8bF.png?st=2023-05-07T15%3A26%3A44Z&se=2023-05-07T17%3A26%3A44Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-07T16%3A18%3A55Z&ske=2023-05-08T16%3A18%3A55Z&sks=b&skv=2021-08-06&sig=4pcJOd8aEI1799liUV13F4ElqO7e4RZy8sa1PEeeNZA%3D

Form 8.3 - The Vanguard Group, Inc.: AVEVA Group plc

Form 8.3 - The Vanguard Group, Inc.: AVEVA Group plc

0

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plcPhoto, wide shot, wide-angle lens, soft focus, Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc

0